The DOI matches its Crossref record; 209 of the 209 references it cites were found in a registry or an index.
Non-coding RNA in hepatocellular carcinoma: Mechanisms, biomarkers and therapeutic targets
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Li, T., Xie, J., Shen, C., Cheng, D., Shi, Y., Wu, Z., Deng, X., Chen, H., Shen, B., Peng, C., et al. (2016) · Oncogene · doi:10.1038/onc.2015.223 · Cited by 272
RetractedCancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Ferlay, J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., Parkin, D. M., Forman, D., & Bray, F. (2015) · International Journal of Cancer · doi:10.1002/ijc.29210 · Cited by 28,766
Valadi, H., Ekström, K., Bossios, A., Sjöstrand, M., Lee, J. J., & Lötvall, J. O. (2007) · Nature Cell Biology · doi:10.1038/ncb1596 · Cited by 12,834 · cited 1×
“The siRNA delivery via exosome has little or no toxicity or immunogenicity [191].”
BackgroundLewis, B. P., Burge, C. B., & Bartel, D. P. (2005) · Cell · doi:10.1016/j.cell.2004.12.035 · Cited by 11,855
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
Galle, P. R., Forner, A., Llovet, J. M., Mazzaferro, V., Piscaglia, F., Raoul, J.-L., Schirmacher, P., & Vilgrain, V. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.03.019 · Cited by 11,406
The basics of epithelial-mesenchymal transition
Kalluri, R., & Weinberg, R. A. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39104 · Cited by 10,196 · cited 1×
“EMT is mediated by genetic and epigenetic changes in the cells, for example, activation of transcription factors such as Snail (SNAI1), TWIST, and ZEB1/2, upregulation of mesenchymal-related proteins such as Vimentin (VIM), Fibronectin (FN1), and N-cadherin (CDH2) and downregulation of intercellular junction proteins…”
BackgroundEpithelial-Mesenchymal Transitions in Development and Disease
Thiery, J. P., Acloque, H., Huang, R. Y. J., & Nieto, M. A. (2009) · Cell · doi:10.1016/j.cell.2009.11.007 · Cited by 9,931
Stem cells, cancer, and cancer stem cells
Reya, T., Morrison, S. J., Clarke, M. F., & Weissman, I. L. (2001) · Nature · doi:10.1038/35102167 · Cited by 9,738
Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells
Elbashir, S. M., Harborth, J., Lendeckel, W., Yalcin, A., Weber, K., & Tuschl, T. (2001) · Nature · doi:10.1038/35078107 · Cited by 9,456
EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma
European Association for the Study of the Liver, & European Organisation for Research and Treatment of Cancer (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2011.12.001 · Cited by 5,218
Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis
Gupta, R. A., Shah, N., Wang, K. C., Kim, J., Horlings, H. M., Wong, D. J., Tsai, M.-C., Hung, T., Argani, P., Rinn, J. L., et al. (2010) · Nature · doi:10.1038/nature08975 · Cited by 5,218
Chen, X., Ba, Y., Ma, L., Cai, X., Yin, Y., Wang, K., Guo, J., Zhang, Y., Chen, J., Guo, X., et al. (2008) · Cell Research · doi:10.1038/cr.2008.282 · Cited by 4,560
Forner, A., Llovet, J. M., & Bruix, J. (2012) · The Lancet · doi:10.1016/s0140-6736(11)61347-0 · Cited by 4,022
Silencing of microRNAs in vivo with ‘antagomirs’
Krützfeldt, J., Rajewsky, N., Braich, R., Rajeev, K. G., Tuschl, T., Manoharan, M., & Stoffel, M. (2005) · Nature · doi:10.1038/nature04303 · Cited by 3,949
Wnt signalling in stem cells and cancer
Reya, T., & Clevers, H. (2005) · Nature · doi:10.1038/nature03319 · Cited by 3,666 · cited 14×
“The existence of CSCs has been postulated in many solid tumors including HCC [95].”
BackgroundInfluentialCancer stem cells in solid tumours: accumulating evidence and unresolved questions
Visvader, J. E., & Lindeman, G. J. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2499 · Cited by 3,429
Identification of tissue-specific microRNAs from mouse
Lagos-Quintana, M., Rauhut, R., Yalcin, A., Meyer, J., Lendeckel, W., & Tuschl, T. (2002) · Current Biology · doi:10.1016/s0960-9822(02)00809-6 · Cited by 3,355 · cited 1×
“miR-122 is a marker of hepatocyte-specific differentiation and accounts for 70% of the total adult liver miRNA content [101, 102].”
BackgroundNon-viral vectors for gene-based therapy
Yin, H., Kanasty, R. L., Eltoukhy, A. A., Vegas, A. J., Dorkin, J. R., & Anderson, D. G. (2014) · Nature Reviews Genetics · doi:10.1038/nrg3763 · Cited by 3,123 · cited 1×
“The delivery of lncRNAs can be achieved by injection of “naked” RNA, viral vectors, or in combination with nanoparticles of different compositions [182].”
BackgroundMicroRNA-21 Regulates Expression of the PTEN Tumor Suppressor Gene in Human Hepatocellular Cancer
Meng, F., Henson, R., Wehbe–Janek, H., Ghoshal, K., Jacob, S. T., & Patel, T. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.05.022 · Cited by 2,773
Self-citationThe landscape of long noncoding RNAs in the human transcriptome
Iyer, M. K., Niknafs, Y. S., Malik, R., Singhal, U., Sahu, A., Hosono, Y., Barrette, T. R., Prensner, J. R., Evans, J. R., Zhao, S., et al. (2015) · Nature Genetics · doi:10.1038/ng.3192 · Cited by 2,738 · cited 4×
“The number of newly identified ncRNA genes is increasing and already outnumbers the number of coding transcripts [1].”
BackgroundInfluentialMany roads to maturity: microRNA biogenesis pathways and their regulation
Winter, J., Jung, S., Keller, S., Gregory, R. I., & Diederichs, S. (2009) · Nature Cell Biology · doi:10.1038/ncb0309-228 · Cited by 2,656
Self-citationLong Noncoding RNAs: Cellular Address Codes in Development and Disease
Batista, P. J., & Chang, H. Y. (2013) · Cell · doi:10.1016/j.cell.2013.02.012 · Cited by 2,531 · cited 1×
“Like mRNAs, several lncRNAs are localized to specific cellular compartments, depending on their biological function [6].”
BackgroundThe Noncoding RNA Revolution—Trashing Old Rules to Forge New Ones
Cech, T. R., & Steitz, J. A. (2014) · Cell · doi:10.1016/j.cell.2014.03.008 · Cited by 2,524
Mattick, J. S., & Makunin, I. V. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl046 · Cited by 2,453
Treatment of HCV Infection by Targeting MicroRNA
Janssen, H. L. A., Reesink, H. W., Lawitz, E. J., Zeuzem, S., Rodriguez-Torres, M., Patel, K., van der Meer, A. J., Patick, A. K., Chen, A., Zhou, Y., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1209026 · Cited by 2,204
Revisiting STAT3 signalling in cancer: new and unexpected biological functions
Yu, H., Lee, H., Herrmann, A., Buettner, R., & Jove, R. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3818 · Cited by 2,137
MicroRNA-155 is induced during the macrophage inflammatory response
O'Connell, R. M., Taganov, K. D., Boldin, M. P., Cheng, G., & Baltimore, D. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610731104 · Cited by 1,866
Adenovirus-Associated Virus Vector–Mediated Gene Transfer in Hemophilia B
Nathwani, A. C., Tuddenham, E. G. D., Rangarajan, S., Rosales, C., McIntosh, J., Linch, D. C., Chowdary, P., Riddell, A., Pie, A. J., Harrington, C., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1108046 · Cited by 1,864 · cited 1×
“Non-viral systems are considered safer because AAV can elicit several adverse effects, such as activation of the immune response, mutation of the host genome and possible liver toxicity [200] as well as integrations into driver genes that can lead to overexpression of affected genes [201].”
BackgroundJordan, C. T., Guzman, M. L., & Noble, M. (2006) · New England Journal of Medicine · doi:10.1056/nejmra061808 · Cited by 1,702
Yuan, J.-H., Yang, F., Wang, F., Ma, J.-Z., Guo, Y.-J., Tao, Q.-F., Liu, F., Pan, W., Wang, T.-T., Zhou, C.-C., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.03.010 · Cited by 1,515
Llovet, J. M., Ducreux, M. P., Lencioni, R. A., Bisceglie, A. M. D., Dufour, J., Greten, T. F., Raymond, É., Roskams, T., Mazzaferro, V., Bruix, J., et al. (2012) · Cited by 1,488
The Noncoding RNA MALAT1 Is a Critical Regulator of the Metastasis Phenotype of Lung Cancer Cells
Gutschner, T., Hämmerle, M., Eißmann, M., Hsu, J., Kim, Y., Hung, G., Revenko, A., Arun, G., Stentrup, M., Groß, M., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-2850 · Cited by 1,415
Self-citationRNAi-mediated gene silencing in non-human primates
Zimmermann, T. S., Lee, A. C. H., Akinc, A., Bramlage, B., Bumcrot, D., Fedoruk, M. N., Harborth, J., Heyes, J. A., Jeffs, L. B., John, M., et al. (2006) · Nature · doi:10.1038/nature04688 · Cited by 1,357 · cited 2×
“For instance, a 90% knockdown of Apolipoprotein B (APOB) in the liver of Macaca fascicularis was noted 48h after a single intravenous siRNA injection [181].”
BackgroundDirect regulation of TWIST by HIF-1α promotes metastasis
Yang, M.-H., Wu, M.-Z., Chiou, S.-H., Chen, P.-M., Chang, S.-Y., Liu, C.-J., Teng, S.-C., & Wu, K.-J. (2008) · Nature Cell Biology · doi:10.1038/ncb1691 · Cited by 1,345
Kino, T., Hurt, D. E., Ichijo, T., Nader, N., & Chrousos, G. P. (2010) · Science Signaling · doi:10.1126/scisignal.2000568 · Cited by 1,231
NF-κB and STAT3 – key players in liver inflammation and cancer
He, G., & Karin, M. (2011) · Cell Research · doi:10.1038/cr.2010.183 · Cited by 1,197
Significance of CD90+ Cancer Stem Cells in Human Liver Cancer
Yang, Z. F., Ho, D. W., Ng, M. N., Lau, C. K., Yu, W. C., Ngai, P., Chu, P. W. K., Lam, C. T., Poon, R. T. P., & Fan, S. T. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.01.013 · Cited by 1,188
Dangerous liaisons: STAT3 and NF-κB collaboration and crosstalk in cancer
Grivennikov, S. I., & Karin, M. (2010) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2009.11.005 · Cited by 1,160
Du, R., Lu, K. V., Petritsch, C., Liu, P., Ganss, R., Passegué, E., Song, H., VandenBerg, S., Johnson, R. S., Werb, Z., et al. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.01.034 · Cited by 1,130
Macrophage heterogeneity in liver injury and fibrosis
Tacke, F., & Zimmermann, H. W. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2013.12.025 · Cited by 1,061 · cited 1×
“regeneration, partly by upregulating the expression of the fibrinogenic genes in the liver [70, 71].”
BackgroundNon‐coding RNAs: regulators of disease
Taft, R. J., Pang, K. C., Mercer, T. R., Dinger, M., & Mattick, J. S. (2010) · The Journal of Pathology · doi:10.1002/path.2638 · Cited by 1,058
Wang, J., Liu, X., Wu, H., Ni, P., Gu, Z., Qiao, Y., Chen, N., Sun, F., & Fan, Q. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq285 · Cited by 998
Satoh, S., Daigo, Y., Furukawa, Y., Kato, T., Miwa, N., Nishiwaki, T., Kawasoe, T., Ishiguro, H., Fujita, M., Tokino, T., et al. (2000) · Nature Genetics · doi:10.1038/73448 · Cited by 960
Therapeutic in vivo gene transfer for genetic disease using AAV: Progress and challenges
Mingozzi, F., & High, K. A. (2011) · Nature Reviews Genetics · doi:10.1038/nrg2988 · Cited by 893 · cited 1×
“The adeno-associated virus (AAV) 8 serotype has a strong tropism for the liver, can be administered intravenously [199] and hence is appealing for targeting the liver.”
BackgroundThe delivery of therapeutic oligonucleotides
Juliano, R. L. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw236 · Cited by 854
Iliopoulos, D., Jaeger, S. A., Hirsch, H. A., Bulyk, M. L., & Struhl, K. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.07.023 · Cited by 830
Bruix, J., Raoul, J.-L., Sherman, M., Mazzaferro, V., Bolondi, L., Craxi, A., Galle, P. R., Santoro, A., Beaugrand, M., Sangiovanni, A., et al. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.06.014 · Cited by 822
SINGAL, A., VOLK, M. L., WALJEE, A., SALGIA, R., HIGGINS, P., ROGERS, M. A. M., & MARRERO, J. A. (2009) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2009.04014.x · Cited by 819
MicroRNA-122 plays a critical role in liver homeostasis and hepatocarcinogenesis
Tsai, W.-C., Hsu, S.-D., Hsu, C.-S., Lai, T.-C., Chen, S.-J., Shen, R., Huang, Y., Chen, H.-C., Lee, C.-H., Tsai, T.-F., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci63455 · Cited by 814
Gramantieri, L., Ferracin, M., Fornari, F., Veronese, A., Sabbioni, S., Liu, C.-G., Calin, G. A., Giovannini, C., Ferrazzi, E., Grazi, G. L., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4607 · Cited by 813
Essential metabolic, anti-inflammatory, and anti-tumorigenic functions of miR-122 in liver
Hsu, S.-H., Wang, B., Kota, J., Yu, J., Costinean, S., Kutay, H., Yu, L., Bai, S., La Perle, K., Chivukula, R. R., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci63539 · Cited by 774
Panzitt, K., Tschernatsch, M. M. O., Guelly, C., Moustafa, T., Stradner, M., Strohmaier, H. M., Buck, C. R., Denk, H., Schroeder, R., Trauner, M., et al. (2007) · Gastroenterology · doi:10.1053/j.gastro.2006.08.026 · Cited by 771
Marrero, J. A., Feng, Z., Wang, Y., Nguyen, M. H., Befeler, A. S., Roberts, L. R., Reddy, K. R., Harnois, D., Llovet, J. M., Normolle, D., et al. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.04.005 · Cited by 745
Coulouarn, C., Factor, V. M., Andersen, J. B., Durkin, M. E., & Thorgeirsson, S. S. (2009) · Oncogene · doi:10.1038/onc.2009.211 · Cited by 733
Kojima, K., Takata, A., Vadnais, C., Otsuka, M., Yoshikawa, T., Akanuma, M., Kondo, Y., Kang, Y. J., Kishikawa, T., Kato, N., et al. (2011) · Nature Communications · doi:10.1038/ncomms1345 · Cited by 717
Urban-Klein, B., Werth, S., Abuharbeid, S., Czubayko, F., & Aigner, A. (2005) · Gene Therapy · doi:10.1038/sj.gt.3302425 · Cited by 716
Kong, W., Yang, H., He, L., Zhao, J.-J., Coppola, D., Dalton, W. S., & Cheng, J. Q. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.00941-08 · Cited by 689
Fujimoto, A., Furuta, M., Totoki, Y., Tsunoda, T., Kato, M., Shiraishi, Y., Tanaka, H., Taniguchi, H., Kawakami, Y., Ueno, M., et al. (2016) · Nature Genetics · doi:10.1038/ng.3547 · Cited by 689
Exosomes from marrow stromal cells expressing miR-146b inhibit glioma growth
Katakowski, M., Buller, B., Zheng, X., Lu, Y., Rogers, T., Osobamiro, O., Shu, W., Jiang, F., & Chopp, M. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.02.019 · Cited by 681
Wan, S., Zhao, E., Kryczek, I., Vatan, L., Sadovskaya, A., Ludema, G., Simeone, D. M., Zou, W., & Welling, T. H. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.08.039 · Cited by 675
Nonalcoholic steatohepatitis is associated with altered hepatic MicroRNA expression
Cheung, O., Puri, P., Eicken, C., Contos, M. J., Mirshahi, F., Maher, J. W., Kellum, J. M., Min, H., Luketic, V. A., & Sanyal, A. J. (2008) · Hepatology · doi:10.1002/hep.22569 · Cited by 658
Lou, G., Song, X., Yang, F., Wu, S., Wang, J., Chen, Z., & Liu, Y. (2015) · Journal of Hematology & Oncology · doi:10.1186/s13045-015-0220-7 · Cited by 651
Iliopoulos, D., Hirsch, H. A., Wang, G., & Struhl, K. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1018898108 · Cited by 643
Stealth Me. PEG‐PLA Nanoparticles Avoid Uptake by the Mononuclear Phagocytes System
Bazile, D., Prud'homme, C., Bassoullet, M., Marlard, M., Spenlehauer, G., & Veillard, M. (1995) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600840420 · Cited by 635
Plasma MicroRNA Panel to Diagnose Hepatitis B Virus–Related Hepatocellular Carcinoma
Zhou, J., Yu, L., Gao, X., Hu, J., Wang, J., Dai, Z., Wang, J.-F., Zhang, Z., Lu, S., Huang, X., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.38.2697 · Cited by 635
Wang, Y., He, L., Du, Y., Zhu, P., Huang, G., Luo, J., Yan, X., Ye, B., Li, C., Xia, P., et al. (2015) · Cell Stem Cell · doi:10.1016/j.stem.2015.03.003 · Cited by 634
Bala, S., Petrasek, J., Mundkur, S., Catalano, D., Levin, I., Ward, J., Alao, H., Kodys, K., & Szabo, G. (2012) · Hepatology · doi:10.1002/hep.25873 · Cited by 631
Advances in targeted therapies for hepatocellular carcinoma in the genomic era
Llovet, J. M., Villanueva, A., Lachenmayer, A., & Finn, R. S. (2015) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2015.103 · Cited by 621
Prakash, T. P., Graham, M. J., Yu, J., Carty, R., Low, A., Chappell, A., Schmidt, K., Zhao, C., Aghajan, M., Murray, H. F., et al. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku531 · Cited by 610
Designing Chemically Modified Oligonucleotides for Targeted Gene Silencing
Deleavey, G. F., & Damha, M. J. (2012) · Chemistry & Biology · doi:10.1016/j.chembiol.2012.07.011 · Cited by 589
Dassie, J. P., Liu, X.-Y., Thomas, G. S., Whitaker, R. M., Thiel, K. W., Stockdale, K. R., Meyerholz, D. K., McCaffrey, A. P., McNamara, J. O., & Giangrande, P. H. (2009) · Nature Biotechnology · doi:10.1038/nbt.1560 · Cited by 589
Tsai, W.-C., Hsu, P. W.-C., Lai, T.-C., Chau, G.-Y., Lin, C.-W., Chen, C.-M., Lin, C.-D., Liao, Y.-L., Wang, J.-L., Chau, Y.-P., et al. (2009) · Hepatology · doi:10.1002/hep.22806 · Cited by 583
Xu, J., Wu, C., Che, X., Wang, L., Yu, D., Zhang, T., Huang, L., Li, H., Tan, W., Wang, C., et al. (2011) · Molecular Carcinogenesis · doi:10.1002/mc.20712 · Cited by 567
Gironella, M., Seux, M., Xie, M.-J., Cano, C., Tomasini, R., Gommeaux, J., Garcia, S., Nowak, J., Yeung, M. L., Jeang, K.-T., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0703942104 · Cited by 551
Chase, A., & Cross, N. C. P. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2156 · Cited by 548
Silva, M. A., Hegab, B., Hyde, C., Guo, B., Buckels, J. A. C., & Mirza, D. F. (2008) · Gut · doi:10.1136/gut.2008.149062 · Cited by 536
Bipotential Adult Liver Progenitors Are Derived from Chronically Injured Mature Hepatocytes
Tarlow, B. D., Pelz, C., Naugler, W. E., Wakefield, L., Wilson, E. M., Finegold, M. J., & Grompe, M. (2014) · Cell Stem Cell · doi:10.1016/j.stem.2014.09.008 · Cited by 533 · cited 1×
“CSCs are a population of cancer cells that can form tumors and possess the properties of self-renewal, and differentiation [94].”
BackgroundWhole-genome sequencing identifies recurrent mutations in hepatocellular carcinoma
Kan, Z., Zheng, H., Liu, X., Li, S., Barber, T. D., Gong, Z., Gao, H., Hao, K., Willard, M. D., Xu, J., et al. (2013) · Genome Research · doi:10.1101/gr.154492.113 · Cited by 523
Jiang, J., Gusev, Y., Aderca, I., Mettler, T. A., Nagorney, D. M., Brackett, D. J., Roberts, L. R., & Schmittgen, T. D. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0523 · Cited by 511
Nanoparticle-based therapy in an in vivo microRNA-155 (miR-155)-dependent mouse model of lymphoma
Babar, I. A., Cheng, C. J., Booth, C. J., Liang, X., Weidhaas, J. B., Saltzman, W. M., & Slack, F. J. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1201516109 · Cited by 497
Recurrent AAV2-related insertional mutagenesis in human hepatocellular carcinomas
Nault, J.-C., Datta, S., Imbeaud, S., Franconi, A., Mallet, M., Couchy, G., Letouzé, E., Pilati, C., Verret, B., Blanc, J.-F., et al. (2015) · Nature Genetics · doi:10.1038/ng.3389 · Cited by 489
Yang, F., Huo, X.-S., Yuan, S.-X., Zhang, L., Zhou, W.-P., Wang, F., & Sun, S.-H. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.01.010 · Cited by 477
He, G., Dhar, D., Nakagawa, H., Font-Burgada, J., Ogata, H., Jiang, Y., Shalapour, S., Seki, E., Yost, S. E., Jepsen, K., et al. (2013) · Cell · doi:10.1016/j.cell.2013.09.031 · Cited by 474
Lennox, K. A., & Behlke, M. A. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkv1206 · Cited by 453
Li, L.-M., Hu, Z.-B., Zhou, Z.-X., Chen, X., Liu, F.-Y., Zhang, J.-F., Shen, H.-B., Zhang, C.-Y., & Zen, K. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1001 · Cited by 451
Hong, D., Kurzrock, R., Kim, Y., Woessner, R., Younes, A., Nemunaitis, J., Fowler, N., Zhou, T., Schmidt, J., Jo, M., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aac5272 · Cited by 445
An HNF4α-miRNA Inflammatory Feedback Circuit Regulates Hepatocellular Oncogenesis
Hatziapostolou, M., Polytarchou, C., Aggelidou, E., Drakaki, A., Poultsides, G. A., Jaeger, S. A., Ogata, H., Karin, M., Struhl, K., Hadzopoulou-Cladaras, M., et al. (2011) · Cell · doi:10.1016/j.cell.2011.10.043 · Cited by 445
Wang, F., Yuan, J.-H., Wang, S.-B., Yang, F., Yuan, S.-X., Ye, C., Yang, N., Zhou, W.-P., Li, W.-L., Li, W., et al. (2014) · Hepatology · doi:10.1002/hep.27239 · Cited by 440
Quagliata, L., Matter, M. S., Piscuoglio, S., Arabi, L., Ruiz, C., Procino, A., Kovac, M., Moretti, F., Makowska, Z., Boldanova, T., et al. (2014) · Hepatology · doi:10.1002/hep.26740 · Cited by 434
Self-citationLiver-specific microRNA-122: Biogenesis and function
Jopling, C. (2012) · RNA Biology · doi:10.4161/rna.18827 · Cited by 415
Yuan, S., Wang, J., Yang, F., Tao, Q., Zhang, J., Wang, L., Yang, Y., Liu, H., Wang, Z., Xu, Q., et al. (2016) · Hepatology · doi:10.1002/hep.27893 · Cited by 404
Ma, S., Tang, K. H., Chan, Y. P., Lee, T. K., Kwan, P. S., Castilho, A., Ng, I., Man, K., Wong, N., To, K.-F., et al. (2010) · Cell Stem Cell · doi:10.1016/j.stem.2010.11.010 · Cited by 383
Wnt/β-Catenin Signaling Contributes to Activation of Normal and Tumorigenic Liver Progenitor Cells
Yang, W., Yan, H.-X., Chen, L., Liu, Q., He, Y.-Q., Yu, L.-X., Zhang, S.-H., Huang, D.-D., Tang, L., Kong, X.-N., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6691 · Cited by 378
Circulating microRNA-21 as a novel biomarker for hepatocellular carcinoma
Tomimaru, Y., Eguchi, H., Nagano, H., Wada, H., Kobayashi, S., Marubashi, S., Tanemura, M., Tomokuni, A., Takemasa, I., Umeshita, K., et al. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2011.04.026 · Cited by 361
Amplification of PVT1 Contributes to the Pathophysiology of Ovarian and Breast Cancer
Guan, Y., Kuo, W.-L., Stilwell, J. L., Takano, H., Lapuk, A. V., Fridlyand, J., Mao, J.-H., Yu, M., Miller, M. A., Santos, J. L., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2882 · Cited by 347
Liver stem cells and hepatocellular carcinoma†
Mishra, L., Banker, T., Murray, J., Byers, S., Thenappan, A., He, A. R., Shetty, K., Johnson, L., & Reddy, E. P. (2009) · Hepatology · doi:10.1002/hep.22704 · Cited by 333
Long non-coding RNA GAS5 regulates apoptosis in prostate cancer cell lines
Pickard, M. R., Mourtada-Maarabouni, M., & Williams, G. T. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.05.005 · Cited by 331
Huang, J.-F., Guo, Y.-J., Zhao, C.-X., Yuan, S.-X., Wang, Y., Tang, G.-N., Zhou, W.-P., & Sun, S.-H. (2013) · Hepatology · doi:10.1002/hep.26195 · Cited by 323
Lachenmayer, A., Alsinet, C., Savic, R., Cabellos, L., Toffanin, S., Hoshida, Y., Villanueva, A., Minguez, B., Newell, P., Tsai, H.-W., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-2322 · Cited by 306
Wang, B., Majumder, S., Nuovo, G., Kutay, H., Volinia, S., Patel, T., Schmittgen, T. D., Croce, C., Ghoshal, K., & Jacob, S. T. (2009) · Hepatology · doi:10.1002/hep.23100 · Cited by 304
Self-citationZhang, Y., Wei, W., Cheng, N., Wang, K., Li, B., Jiang, X., & Sun, S. (2012) · Hepatology · doi:10.1002/hep.25849 · Cited by 300
Kim, S.-Y., Kang, J. W., Song, X., Kim, B. K., Yoo, Y. D., Kwon, Y. T., & Lee, Y. J. (2013) · Cellular Signalling · doi:10.1016/j.cellsig.2013.01.007 · Cited by 297
Diagnostic and prognostic implications of microRNAs in human hepatocellular carcinoma
Li, W., Xie, L., He, X., Li, J., Tu, K., Wei, L., Wu, J., Guo, Y., Ma, X., Zhang, P., et al. (2008) · International Journal of Cancer · doi:10.1002/ijc.23693 · Cited by 293
Plasma HULC as a Promising Novel Biomarker for the Detection of Hepatocellular Carcinoma
Xie, H., Ma, H., & Zhou, D. (2013) · BioMed Research International · doi:10.1155/2013/136106 · Cited by 290
Long non-coding RNA DILC regulates liver cancer stem cells via IL-6/STAT3 axis
Wang, X., Sun, W., Shen, W., Xia, M., Chen, C., Xiang, D., Ning, B., Cui, X., Li, H., Li, X., et al. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.01.019 · Cited by 290
Amplification of Long Noncoding RNA ZFAS1 Promotes Metastasis in Hepatocellular Carcinoma
Li, T., Xie, J., Shen, C., Cheng, D., Shi, Y., Wu, Z., Deng, X., Chen, H., Shen, B., Peng, C., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-3721 · Cited by 289
Wisse, E., Jacobs, F., Topal, B., Frederik, P., & De Geest, B. (2008) · Gene Therapy · doi:10.1038/gt.2008.60 · Cited by 289
Subramaniam, A., Shanmugam, M. K., Perumal, E., Li, F., Nachiyappan, A., Dai, X., Swamy, S. N., Ahn, K. S., Kumar, A. P., Tan, B. K. H., et al. (2013) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2012.10.002 · Cited by 278
From junk to master regulators of invasion: lncRNA functions in migration, EMT and metastasis
Dhamija, S., & Diederichs, S. (2016) · International Journal of Cancer · doi:10.1002/ijc.30039 · Cited by 272
Self-citationViral-Human Chimeric Transcript Predisposes Risk to Liver Cancer Development and Progression
Lau, C.-C., Sun, T., Ching, A. K. K., He, M., Li, J.-W., Wong, A. M., Co, N. N., Chan, A. W. H., Li, P.-S., Lung, R. W. M., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.01.030 · Cited by 270
Li, S.-P., Xu, H.-X., Yu, Y., He, J.-D., Wang, Z., Xu, Y.-J., Wang, C.-Y., Zhang, H.-M., Zhang, R.-X., Zhang, J.-J., et al. (2106) · Oncotarget · doi:10.18632/oncotarget.9883 · Cited by 268
Zhuang, J., Lu, Q., Shen, B., Huang, X., Shen, L., Zheng, X., Huang, R., Yan, J., & Guo, H. (2015) · Scientific Reports · doi:10.1038/srep11924 · Cited by 252
Cytoplasmic long noncoding RNAs are frequently bound to and degraded at ribosomes in human cells
Carlevaro-Fita, J., Rahim, A., Guigó, R., Vardy, L. A., & Johnson, R. (2016) · RNA · doi:10.1261/rna.053561.115 · Cited by 239
Hämmerle, M., Gutschner, T., Uckelmann, H., Ozgur, S., Fiskin, E., Gross, M., Skawran, B., Geffers, R., Longerich, T., Breuhahn, K., et al. (2013) · Hepatology · doi:10.1002/hep.26537 · Cited by 236
Self-citationMicroRNA-based classification of hepatocellular carcinoma and oncogenic role of miR-517a
Toffanin, S., Hoshida, Y., Lachenmayer, A., Villanueva, A., Cabellos, L., Minguez, B., Savic, R., Ward, S. C., Thung, S., Chiang, D. Y., et al. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.02.009 · Cited by 232
Takahashi, K., Yan, I. K., Haga, H., & Patel, T. (2014) · Journal of Cell Science · doi:10.1242/jcs.141069 · Cited by 231
Self-citationlnc-β-Catm elicits EZH2-dependent β-catenin stabilization and sustains liver CSC self-renewal
Zhu, P., Wang, Y., Huang, G., Ye, B., Liu, B., Wu, J., Du, Y., He, L., & Fan, Z. (2016) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.3235 · Cited by 231
Cao, C., Sun, J., Zhang, D., Guo, X., Xie, L., Li, X., Wu, D., & Liu, L. (2015) · Gastroenterology · doi:10.1053/j.gastro.2014.10.012 · Cited by 230
Liu, A. M., Yao, T.-J., Wang, W., Wong, K.-F., Lee, N. P., Fan, S. T., Poon, R. T. P., Gao, C., & Luk, J. M. (2012) · BMJ Open · doi:10.1136/bmjopen-2012-000825 · Cited by 226
Gui, J., Tian, Y., Wen, X., Zhang, W., Zhang, P., Gao, J., Run, W., Tian, L., Jia, X., & Gao, Y. (2011) · Clinical Science · doi:10.1042/cs20100297 · Cited by 222
Delivery systems for siRNA drug development in cancer therapy
Xu, C.-F., & Wang, J. (2015) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2014.08.011 · Cited by 219
HULC and Linc00152 Act as Novel Biomarkers in Predicting Diagnosis of Hepatocellular Carcinoma
Li, J., Wang, X., Tang, J., Jiang, R., Zhang, W., Ji, J., & Sun, B. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000430387 · Cited by 211
Expression of serum miR-221 in human hepatocellular carcinoma and its prognostic significance
Li, J., Wang, Y., Yu, W., Chen, J., & Luo, J. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.01.111 · Cited by 209
Wu, H., Ng, R., Chen, X., Steer, C. J., & Song, G. (2016) · Gut · doi:10.1136/gutjnl-2014-308430 · Cited by 206
Meng, Z., Fu, X., Chen, X., Zeng, S., Tian, Y., Jove, R., Xu, R., & Huang, W. (2010) · Hepatology · doi:10.1002/hep.23915 · Cited by 204
Enhanced Self-Renewal Capability in Hepatic Stem/Progenitor Cells Drives Cancer Initiation
Chiba, T., Zheng, Y.-W., Kita, K., Yokosuka, O., Saisho, H., Onodera, M., Miyoshi, H., Nakano, M., Zen, Y., Nakanuma, Y., et al. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.06.016 · Cited by 204
Structural basis for telomerase catalytic subunit TERT binding to RNA template and telomeric DNA
Mitchell, M., Gillis, A., Futahashi, M., Fujiwara, H., & Skordalakes, E. (2010) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1777 · Cited by 201
TGF-β-induced epithelial-mesenchymal transition: A link between cancer and inflammation
Fuxe, J., & Karlsson, M. C. I. (2012) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2012.05.004 · Cited by 198
Exploration of liver cancer genomes
Shibata, T., & Aburatani, H. (2014) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2014.6 · Cited by 197
Inagawa, S., Itabashi, M., Adachi, S., Kawamoto, T., Hori, M., Shimazaki, J., Yoshimi, F., & Fukao, K. (2002) · PubMed · Cited by 196
Tang, J., Zhuo, H., Zhang, X., Jiang, R., Ji, J., Deng, L., Qian, X., Zhang, F., & Sun, B. (2014) · Cell Death & Disease · doi:10.1038/cddis.2014.518 · Cited by 195
Gutschner, T., Hämmerle, M., Pazaitis, N., Bley, N., Fiskin, E., Uckelmann, H., Heim, A., Groβ, M., Hofmann, N., Geffers, R., et al. (2014) · Hepatology · doi:10.1002/hep.26997 · Cited by 193
Self-citationChen, Z.-Z., Huang, L., Wu, Y.-H., Zhai, W.-J., Zhu, P.-P., & Gao, Y.-F. (2016) · Nature Communications · doi:10.1038/ncomms12598 · Cited by 193
Xu, D., Yang, F., Yuan, J.-H., Zhang, L., Bi, H.-S., Zhou, C.-C., Liu, F., Wang, F., & Sun, S.-H. (2013) · Hepatology · doi:10.1002/hep.26361 · Cited by 185
Serum microRNA-1 and microRNA-122 are prognostic markers in patients with hepatocellular carcinoma
Köberle, V., Kronenberger, B., Pleli, T., Trojan, J., Imelmann, E., Peveling-Oberhag, J., Welker, M.-W., Elhendawy, M., Zeuzem, S., Piiper, A., et al. (2013) · European Journal of Cancer · doi:10.1016/j.ejca.2013.06.002 · Cited by 184
Liu, F., Yuan, J.-H., Huang, J.-F., Yang, F., Wang, T.-T., Ma, J.-Z., Zhang, L., Zhou, C.-C., Wang, F., Yu, J., et al. (2016) · Oncogene · doi:10.1038/onc.2016.80 · Cited by 183
Casero, D., Sandoval, S., Seet, C. S., Scholes, J., Zhu, Y., Ha, V. L., Luong, A., Parekh, C., & Crooks, G. M. (2015) · Nature Immunology · doi:10.1038/ni.3299 · Cited by 179
Cationic lipid nanoparticles for therapeutic delivery of siRNA and miRNA to murine liver tumor
Hsu, S.-H., Yu, B., Wang, X., Lu, Y., Schmidt, C. R., Lee, R. J., Lee, L. J., Jacob, S. T., & Ghoshal, K. (2013) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2013.05.007 · Cited by 173
Tan, Y., Ge, G., Pan, T., Wen, D., Chen, L., Xuejun, Y., Zhou, X., & Gan, J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0107986 · Cited by 168
Xia, H., Ooi, L. L. P. J., & Hui, K. M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044206 · Cited by 164
Combined α fetoprotein testing and ultrasonography as a screening test for primary liver cancer
Zhang, B., & Yang, B. (1999) · Journal of Medical Screening · doi:10.1136/jms.6.2.108 · Cited by 162
miRNA regulation of cytokine genes
Asirvatham, A. J., Magner, W. J., & Tomasi, T. B. (2009) · Cytokine · doi:10.1016/j.cyto.2008.11.010 · Cited by 161
Hepatic stem cells and transforming growth factor β in hepatocellular carcinoma
Majumdar, A., Curley, S. A., Wu, X., Brown, P., Hwang, J. P., Shetty, K., Yao, Z.-X., He, A. R., Li, S., Katz, L., et al. (2012) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2012.114 · Cited by 161
Hu, J., Song, W., Zhang, S., Shen, X., Qiu, X., Wu, H., Gong, P., Lu, S., Zhao, Z., He, M., et al. (2016) · Scientific Reports · doi:10.1038/srep23521 · Cited by 156
Zhang, H., Diab, A., Fan, H., Mani, S. K. K., Hullinger, R. L., Merle, P., & ANDRISANI, O. M. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-2928 · Cited by 146
Tang, J., Jiang, R., Deng, L., Zhang, X., Wang, K., & Sun, B. (2015) · Oncotarget · doi:10.18632/oncotarget.2934 · Cited by 142
MiR-124 suppresses cell proliferation in hepatocellular carcinoma by targeting PIK3CA
Lang, Q.-B., & Ling, C. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.08.075 · Cited by 142
Kamel, M. M., Matboli, M., Sallam, M. M., Montasser, I. F., Saad, A. S., & El‐Tawdi, A. (2015) · Translational research · doi:10.1016/j.trsl.2015.10.002 · Cited by 141
Zhang, H., Xing, Z., Mani, S. K. K., Bancel, B., Durantel, D., Zoulim, F., Tran, E. J., Merle, P., & ANDRISANI, O. M. (2016) · Hepatology · doi:10.1002/hep.28698 · Cited by 141
Liang, H., Wang, N., Wang, Y., Wang, F., Fu, Z., Yan, X., Zhu, H., Diao, W., Ding, Y., Chen, X., et al. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.09.013 · Cited by 124
CHANG, L., Li, C., Lan, T., Wu, L., Yuan, Y., Liu, Q., & Liu, Z. (2015) · Molecular Medicine Reports · doi:10.3892/mmr.2015.4716 · Cited by 124
Han, Z., Chen, H., Fan, J., Wu, J., Tang, H., & Peng, Z. (2011) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-011-1076-z · Cited by 123
Zhou, C., Yang, F., Yuan, S., Ma, J., Liu, F., Yuan, J., Bi, F., Lin, K., Yin, J., Cao, G., et al. (2015) · Hepatology · doi:10.1002/hep.28393 · Cited by 122
Induction of drug resistance and transformation in human cancer cells by the noncoding RNA CUDR
Tsang, W. P., Wong, T. W. L., Cheung, H., Co, C., & Kwok, T. T. (2007) · RNA · doi:10.1261/rna.359007 · Cited by 120
Qiu, X., Dong, S., Qiao, F., Lü, S., Song, Y., Lao, Y., Li, Y., Zeng, T., Hu, J., Zhang, L., et al. (2013) · Oncogene · doi:10.1038/onc.2013.150 · Cited by 118
Hepatocyte nuclear factor 4α-nuclear factor-κB feedback circuit modulates liver cancer progression
Ning, B., Ding, J., Liu, J., Yin, C., Xu, W., Cong, W., Zhang, Q., Chen, F., Han, T., Deng, X., et al. (2014) · Hepatology · doi:10.1002/hep.27177 · Cited by 108
Serum miR-18a: A Potential Marker for Hepatitis B Virus-Related Hepatocellular Carcinoma Screening
Li, L., Guo, Z., Wang, J., Mao, Y., & Gao, Q. (2012) · Digestive Diseases and Sciences · doi:10.1007/s10620-012-2317-y · Cited by 105
Guo, W., Liu, S., Cheng, Y., Lü, L., Shi, J., Xu, G., Li, N., Cheng, K., Wu, M., Cheng, S., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-3106 · Cited by 105
Systematic Review and Meta‐Analysis: Circulating miRNAs for Diagnosis of Hepatocellular Carcinoma
Huang, J., Liu, S., Ma, H., Yang, Y., Zhang, X., Sun, H., Zhang, X., Xu, J., & Wang, J. (2015) · Journal of Cellular Physiology · doi:10.1002/jcp.25135 · Cited by 104
Molecular mechanisms controlling the phenotype and the EMT / MET dynamics of hepatocyte
Cicchini, C., Amicone, L., Alonzi, T., Marchetti, A., Mancone, C., & Tripodi, M. (2014) · Liver International · doi:10.1111/liv.12577 · Cited by 100
Role of MicroRNAs in NAFLD/NASH
Szabó, G., & Csák, T. (2016) · Digestive Diseases and Sciences · doi:10.1007/s10620-015-4002-4 · Cited by 99
Destabilization of B2 RNA by EZH2 Activates the Stress Response
Zovoilis, A., Cifuentes‐Rojas, C., Chu, H.-P. C., Hernandez, A. J., & Lee, J. T. (2016) · Cell · doi:10.1016/j.cell.2016.11.041 · Cited by 98
The Wnt/β-catenin pathway as a therapeutic target in human hepatocellular carcinoma
Dahmani, R., Just, P., & Perret, C. (2011) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2011.05.010 · Cited by 96
Liu, F., Kong, X., Lv, L. L., & Gao, J. X. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.01.030 · Cited by 96
MiR-214 inhibits cell growth in hepatocellular carcinoma through suppression of β-catenin
Wang, X., Ji, C., Feng, L., Lin, Y., Zhang, X., Lv, Z., & Jiang, J. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.10.039 · Cited by 95
Konishi, H., Ichikawa, D., Yamamoto, Y., Arita, T., Shoda, K., Hiramoto, H., Hamada, J., Itoh, H., Fujita, Y., Komatsu, S., et al. (2015) · Cancer Science · doi:10.1111/cas.12854 · Cited by 95
Long non-coding RNA PVT1 activates hepatic stellate cells through competitively binding microRNA-152
Zheng, J., Yu, F., Dong, P., Wu, L., Zhang, Y., Hu, Y., & Zheng, L. (2016) · Oncotarget · doi:10.18632/oncotarget.11709 · Cited by 94
Lagarde, J., Uszczyńska-Ratajczak, B., Santoyo‐López, J., González, J. M., Tapanari, E., Mudge, J. M., Steward, C. A., Wilming, L. G., Tanzer, A., Howald, C., et al. (2016) · Nature Communications · doi:10.1038/ncomms12339 · Cited by 92
Ma, X., WANG, X., Yang, C., Wang, Z., Han, B., Wu, L., & Zhuang, L. (2016) · Anticancer Research · doi:10.21873/anticanres.11236 · Cited by 90
Qian, H., Deng, X., Huang, Z., Wei, J., Ding, C., Feng, R.-X., Zeng, X. Y., Chen, Y.-X., Ding, J., Qiu, L., et al. (2015) · Cell Research · doi:10.1038/cr.2015.84 · Cited by 89
TRIM28 interacts with EZH2 and SWI/SNF to activate genes that promote mammosphere formation
Li, J.-D., Xi, Y., Li, W., McCarthy, R. L., Stratton, S. A., Zou, W., Li, W., Dent, S., Jain, A. K., & Barton, M. C. (2017) · Oncogene · doi:10.1038/onc.2016.453 · Cited by 86
Bao, C., Li, Y., Huan, L., Zhang, Y., Zhao, F., Wang, Q., Liang, L., Ding, J., Liu, L., Chen, T., et al. (2015) · Science Signaling · doi:10.1126/scisignal.aaa8441 · Cited by 84
MicroRNA-124 suppresses growth of human hepatocellular carcinoma by targeting STAT3
Lu, Y., Yue, X., Cui, Y., Zhang, J., & Wang, K. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.10.157 · Cited by 84
Liu, J.-Y., Chiang, T., Liu, C.-H., Chern, G.-G., Lin, T.-T., Gao, D.-Y., & Chen, Y. (2015) · Molecular Therapy · doi:10.1038/mt.2015.147 · Cited by 83
Wang, J., Li, J.-W., Wang, X.-C., Zheng, C., & Ma, W.-D. (2013) · Biochemical and Biophysical Research Communications - BBRC · doi:10.1016/j.bbrc.2013.08.032 · Cited by 81
Long and Short Non-Coding RNAs as Regulators of Hematopoietic Differentiation
Morceau, F., Chateauvieux, S., Gaigneaux, A., Dicato, M. A., & Diederich, M. F. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms140714744 · Cited by 81
Yu, J., Han, J., Zhang, J., Li, G., Liu, H., Cui, X., Xu, Y., Li, T., Liu, J., & Wang, C. (2016) · Medicine · doi:10.1097/md.0000000000004436 · Cited by 79
TP53INP1 decreases pancreatic cancer cell migration by regulating SPARC expression
Seux, M., Peuget, S., Montero, M.-P., Siret, C., Rigot, V., Clerc, P., Gigoux, V., Pellegrino, E., Pouyet, L., N’guessan, P., et al. (2011) · Oncogene · doi:10.1038/onc.2011.25 · Cited by 76
Zheng, Z., Liu, J., Yang, Z., Wu, L., Xie, H., Jiang, C., Lin, B.-Y., Chen, T., Xing, C., Liu, Z., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.8584 · Cited by 74
Zhang, H., Zhu, C., Zhao, Y. C., Li, M., Wu, L., Yang, X., Wan, X., Wang, A., Zhang, M. Q., Sang, X., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.6087 · Cited by 72
Wang, T., Yu, C., Lin, Y.-S., Chen, T., Yeh, C., Liang, K., Shieh, T., Chen, C., & Hsueh, C. (2016) · Oncotarget · doi:10.18632/oncotarget.9635 · Cited by 70
Lu, J., Xie, F., Li, G., Shen, W., Sui, C., & Yang, J. (2014) · Tumor Biology · doi:10.1007/s13277-014-2951-4 · Cited by 69
Yoon, S. O., Chun, S., Han, E. H., Choi, J., Jang, S. J., Koh, S. A., Hwang, S., & Yu, E. (2011) · Human Pathology · doi:10.1016/j.humpath.2010.12.010 · Cited by 67
Wang, K., Guo, W. X., Li, N., Gao, C., Shi, J., Tang, Y., Shen, F., Wu, M. C., Liu, S. R., & Cheng, S. (2015) · PLoS ONE · doi:10.1371/journal.pone.0144934 · Cited by 63
Ma, W., Wang, H., Wei, J., Zhou, F., Chang, L., Hong, Z., Liu, H., Liu, Z., & Yuan, Y. (2016) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2016.09.002 · Cited by 63
Potential diagnostic value of lncRNA SPRY4-IT1 in hepatocellular carcinoma
Wei, J., Gao, S., Zhu, M., Luo, P., Jing, X., Chai, H., & Tu, J. (2016) · Oncology Reports · doi:10.3892/or.2016.4859 · Cited by 62
Roberts, T. C. (2015) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-22380-3_2 · Cited by 55
Circulating microRNA-122a as a diagnostic marker for hepatocellular carcinoma
Deng, S., Luo, C., Chen, Huang, Yuan, Z., Zhang, K., & Zhang, K. (2013) · OncoTargets and Therapy · doi:10.2147/ott.s44215 · Cited by 53
Hackermüller, J., Reiche, K., Otto, C., Hösler, N., Blumert, C., Brocke-Heidrich, K., Böhlig, L., Nitsche, A., Kasack, K., Ahnert, P., et al. (2014) · Genome biology · doi:10.1186/gb-2014-15-3-r48 · Cited by 52
Canonical and Non-Canonical Barriers Facing AntimiR Cancer Therapeutics
Cheng, C., Saltzman, W. M., & Slack, F. J. (2013) · Current Medicinal Chemistry · doi:10.2174/0929867311320290004 · Cited by 51
SOX7: from a developmental regulator to an emerging tumor suppressor.
Stovall, D. B., Cao, P. D., & Sui, G. (2014) · PubMed · doi:10.14670/hh-29.10.439 · Cited by 51
Emerging role of microRNA in hepatocellular carcinoma (Review)
Gong, J., He, X., & Tian, D. (2014) · Oncology Letters · doi:10.3892/ol.2014.2816 · Cited by 50
Involvement of inflammation and its related microRNAs in hepatocellular carcinoma
Jin, K., Li, T., Sánchez‐Duffhues, G., Zhou, F., & Zhang, L. (2016) · Oncotarget · doi:10.18632/oncotarget.13530 · Cited by 50
Downregulation of miR-452 Promotes Stem-Like Traits and Tumorigenicity of Gliomas
Liu, L., Chen, K., Wu, J., Shi, L., Hu, B., Cheng, S., Li, M., & Song, L. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-3794 · Cited by 49
Okada, H., Honda, M., Campbell, J. S., Takegoshi, K., Sakai, Y., Yamashita, T., Shirasaki, T., Takabatake, R., Nakamura, M., Tanaka, T., et al. (2015) · Cancer Science · doi:10.1111/cas.12730 · Cited by 47
Roles of MicroRNAs in the Life Cycles of Mammalian Viruses
Gottwein, E. (2013) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-37765-5_8 · Cited by 46
Evaluation of Circulatory RNA-Based Biomarker Panel in Hepatocellular Carcinoma
El‐Tawdi, A., Matboli, M., Shehata, H. H., Tash, F., El-Khazragy, N. N., Azazy, A. E., & Abdel-Rahman, O. M. (2016) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-016-0200-9 · Cited by 46
Li, X., Su, Y., Sun, B., Ji, W., Peng, Z., Xu, Y., Wu, M., & Su, C. (2016) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-16-0096 · Cited by 46
Integrative analysis of aberrant Wnt signaling in hepatitis B virus-related hepatocellular carcinoma
Ding, S., Yang, Z., Wang, J., Zhang, X., Chen, X., & Lu, F. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i20.6317 · Cited by 44
Expanding the functional role of long noncoding RNAs
Johnsson, P., & Morris, K. V. (2014) · Cell Research · doi:10.1038/cr.2014.104 · Cited by 42
Cited by
Targeting PI3K in cancer: mechanisms and advances in clinical trials
Yang, J., Nie, J., Ma, X., Wei, Y., Peng, Y., & Wei, X. (2019) · Molecular Cancer · doi:10.1186/s12943-019-0954-x · Cited by 1,520
Signaling pathways in cancer-associated fibroblasts and targeted therapy for cancer
Wu, F., Yang, J., Liu, J., Wang, Y., Mu, J., Zeng, Q., Deng, S., & Zhou, H. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00641-0 · Cited by 773
The role of long noncoding RNAs in hepatocellular carcinoma
Huang, Z., Zhou, J.-K., Peng, Y., He, W., & Huang, C. (2020) · Molecular Cancer · doi:10.1186/s12943-020-01188-4 · Cited by 511
Wang, Y., Yang, L., Chen, T., Liu, X., Guo, Y., Zhu, Q., Tong, X., Yang, W., Xu, Q., Huang, D., et al. (2019) · Molecular Cancer · doi:10.1186/s12943-019-0957-7 · Cited by 411
β-Catenin signaling in hepatocellular carcinoma
Xu, C., Xu, Z., Zhang, Y., Evert, M., Calvisi, D. F., & Chen, X. (2022) · Journal of Clinical Investigation · doi:10.1172/jci154515 · Cited by 305
Metadata
- Authors
- Klingenberg, M., Matsuda, A., Diederichs, S., & Patel, T.
- Venue
- Journal of Hepatology
- Publisher
- Elsevier BV
- Published
- 2017-09
- Volume
- 67
- Issue
- 3
- Pages
- 603-619
- ISSN
- 0168-8278 (ISSN-L)
- OpenAlex
- W2607190220
- Cited by
- 354
- References
- 209
- FWCI
- 14.41
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.